Joint Stock

Joint EBITDA per Share

The EBITDA per Share of Joint (JYNT) as of Aug 5, 2026 is 0.05 USD. In the previous year, EBITDA per Share was -0.03 USD — a change of -246.47% (higher).

EBITDA per Share

0.05USD

YoY

-246.47%

Last updated:

EBITDA per Share of Joint is 2026 0.05 USD. EBITDA per Share of Joint was 2025 -0.03 USD. It decreases by -246.47% higher compared to the previous year.
Access this data via the Eulerpool API

Joint Stock analysis

What does Joint do? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Joint stock

EBITDA per Share of Joint is 0.05 USD in 2026.

EBITDA per Share of Joint changed from -0.03 USD to 0.05 USD, representing a -246.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Joint since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Joint

All Key Metrics — Joint